France Pharmaceutical and Medical Goods Expenditure Share (2025)
France's Pharmaceutical and Medical Goods Expenditure Share: 17.2 % of current health expenditure in 2025, -0.2pp YoY. Eurostat (HLTH_SHA11_HC), 2006–2025.
France (2025)
17.2
% of current health expenditure
-0.2pp YoY
YoY Change
-0.2pp
percentage points
Trend
down
Series length
20
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2025 | 17.2 | -0.2pp |
| 2024 | 17.4 | +0.1pp |
| 2023 | 17.3 | -0.2pp |
| 2022 | 17.5 | +0.2pp |
| 2021 | 17.3 | -0.3pp |
| 2020 | 17.6 | -0.9pp |
| 2019 | 18.5 | -0.2pp |
| 2018 | 18.7 | -0.2pp |
| 2017 | 18.9 | -0.2pp |
| 2016 | 19.1 | -0.2pp |
| 2015 | 19.3 | -0.2pp |
| 2014 | 19.5 | unchanged |
| 2013 | 19.5 | -0.5pp |
| 2012 | 20 | -0.3pp |
| 2011 | 20.3 | -0.3pp |
| 2010 | 20.6 | +0.3pp |
| 2009 | 20.3 | -0.5pp |
| 2008 | 20.8 | -0.3pp |
| 2007 | 21.1 | -0.1pp |
| 2006 | 21.2 | n/a |
About this Dataset
France recorded 17.2 % of current health expenditure in 2025. The latest change was -0.2pp. Across 2006–2025 the series ranges from 17.2 % of current health expenditure in 2025 to 21.2 % of current health expenditure in 2006.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in France.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in France. It is published by Eurostat and updated annually.
The most recent observation covers 2025. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2006–2025 (20 observations).
The series is at its lowest recorded level, 17.2 % of current health expenditure in 2025, down from a peak of 21.2 % of current health expenditure in 2006. The latest change was -0.2pp.